is the generic ingredient in one branded drug marketed by Celgene
and is included in one NDA. There are sixteen patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
This ingredient has sixty-nine patent family members
in twenty countries.
There are eight drug master file entries
for thalidomide. One supplier
is listed for this compound.